Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Obsidian Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Obsidian Therapeutics

Obsidian Therapeutics

Series B

Obsidian Therapeutics: A Massachusetts-based biotech firm innovating cell therapies for cancer treatment.

HQ
Cambridge, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Obsidian Therapeutics is a Massachusetts-based biotechnology company focused on developing precision cell and gene therapies for cancer treatment. Utilizing its proprietary cytoDRiVE® platform, Obsidian engineers regulated therapeutic proteins to create advanced adoptive cell therapies. The company's mission is to unlock the promise of precision medicines, offering innovative solutions to improve patient outcomes in oncology.

Obsidian Therapeutics has made significant strides in the biotech industry, including presenting safety and efficacy data for its OBX- product at the American Society of Clinical Oncology (ASCO) Annual Meeting. The company has also strengthened its leadership with the appointment of William Pao, M.D., Ph.D., to its board of directors, underscoring its commitment to scientific excellence and strategic growth.

Obsidian Therapeutics - Similar Companies

Odyssey Therapeutics logo

Odyssey Therapeutics

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Black Diamond Therapeutics logo

Black Diamond Therapeutics

bdtherapeutics.com

OmniCyte logo

OmniCyte

omnicyte.com

C4 Therapeutics logo

C4 Therapeutics

c4therapeutics.com

Ribon Therapeutics logo

Ribon Therapeutics

ribontx.com

Ernexa Therapeutics logo

Ernexa Therapeutics

eternatx.com

GO Therapeutics logo

GO Therapeutics

gotherapeutics.com

Platelet BioGenesis logo

Platelet BioGenesis

Outpace Bio logo

Outpace Bio

outpacebio.com

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

CytomX Therapeutics logo

CytomX Therapeutics

cytomx.com

Shinobi Therapeutics logo

Shinobi Therapeutics

shinobitx.com

HebeCell logo

HebeCell

hebecellcorp.com

Legend Biotech logo

Legend Biotech

legendbiotech.com

Obsidian Therapeutics - Quick Facts

Who are Obsidian Therapeutics' competitors?

Companies similar to Obsidian Therapeutics include Odyssey Therapeutics, Cell BioEngines, Black Diamond Therapeutics and OmniCyte.

When was Obsidian Therapeutics founded?

Obsidian Therapeutics was founded in 2015.

Where is Obsidian Therapeutics' headquarters located?

Obsidian Therapeutics' headquarters is located in Cambridge, MA, US.

When was Obsidian Therapeutics' last funding round?

Obsidian Therapeutics' most recent funding round was for $115M (USD) in September 2021.

How much has Obsidian Therapeutics raised to-date?

As of Sep 9, 2021, Obsidian Therapeutics has raised a total of $164.5M (USD).

How many employees does Obsidian Therapeutics have?

Obsidian Therapeutics has 90 employees as of Feb 5, 2024.

Obsidian Therapeutics - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cell Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified